Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

EL Insider Trading

ESTEE LAUDER COMPANIES INC | Perfumes, Cosmetics & Other Toilet Preparations

Comprehensive Trading Performance Summary

The investment history of corporate insiders at ESTEE LAUDER COMPANIES INC provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Perfumes, Cosmetics & Other Toilet Preparations sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2007-02-03 00:42 2007-01-31 SUSMAN SALLY Officer - Exec.VP, Global Communications OPT+S $46.20 100,000 $4,620,100 840 0.0%
2007-02-03 00:41 2007-01-31 KUNES RICHARD W Officer - Exec. V.P. - CFO OPT+S $46.48 115,000 $5,345,614 2,160 0.0%
2007-01-10 00:05 2007-01-08 BRESTLE DANIEL J Officer - Chief Operating Officer OPT+S $39.85 20,000 $797,060 8,987 0.0%
2006-12-12 00:12 2006-12-08 BRESTLE DANIEL J Officer - Chief Operating Officer OPT+S $41.28 20,000 $825,674 8,987 0.0%
2006-11-29 00:11 2006-11-27 Demsey John Officer - Group President OPT+S $41.28 20,000 $825,530 19 0.0%
2006-11-28 00:10 2006-11-24 Caracappa Roger Officer - EVP-Pkg and Quality Assurance OPT+S $41.49 16,667 $691,470 60 0.0%
2006-11-18 01:34 2006-11-15 LAUDER LEONARD A Director, Officer, 10% owner - Chairman OPT+S $40.56 99,900 $4,052,424 4,619,169 0.0%
2006-11-15 20:19 2006-11-13 LAUDER LEONARD A Director, Officer, 10% owner - Chairman OPT+S $39.75 66,600 $2,647,503 4,619,169 0.0%
2006-11-13 23:31 2006-11-09 LAUDER LEONARD A Director, Officer, 10% owner - Chairman OPT+S $39.78 66,600 $2,649,461 5,369,169 0.0%
2006-11-09 03:53 2006-11-06 LAUDER LEONARD A Director, Officer, 10% owner - Chairman OPT+S $39.93 99,900 $3,988,897 5,369,169 0.0%
2006-11-09 01:09 2006-11-08 BRESTLE DANIEL J Officer - Chief Operating Officer OPT+S $39.92 20,000 $798,396 8,987 0.0%
2006-11-07 00:48 2006-11-03 TRUST F/B/O LAUDER AERIN & JANE U/A/D 12/15/76 BY ESTEE &JHL 10% owner SELL $39.28 100,000 $3,928,430 0 -100.0%
2006-11-03 01:49 2006-10-31 TRUST F/B/O LAUDER AERIN & JANE U/A/D 12/15/76 BY ESTEE &JHL 10% owner SELL $39.68 400,000 $15,870,080 100,000 -80.0%
2006-11-01 00:21 2006-10-27 TRUST F/B/O LAUDER AERIN & JANE U/A/D 12/15/76 BY ESTEE &JHL 10% owner SELL $40.12 500,000 $20,060,700 0 -100.0%
2006-10-27 00:00 2006-10-25 SUSMAN SALLY Officer - Exec.VP, Global Communications OPT+S $42.94 58,333 $2,504,732 0 0.0%
2006-10-26 23:59 2006-10-25 BOUSQUET CHAVANNE PATRICK Officer - Group President OPT+S $41.67 57,000 $2,375,002 1,322 0.0%
2006-10-26 23:58 2006-10-25 SHEARER PHILIP Officer - Group President OPT+S $42.28 166,666 $7,046,588 0 0.0%
2006-09-29 23:21 2006-09-28 BOUSQUET CHAVANNE PATRICK Officer - Group President OPT+S $41.00 10,000 $410,000 1,322 0.0%
2006-08-31 23:03 2006-08-31 HOBSON MELLODY L Director BUY $36.77 1,000 $36,771 3,000 +50.0%
2006-08-21 23:01 2006-08-18 MOSS SARA E Officer - Exec. VP, Gen. Counsel & Secty BUY $35.43 1,500 $53,145 1,500 +100.0%
2006-03-18 00:50 2006-03-16 LAUDER RONALD S Director, Officer, 10% owner - Chairman, Clinique Labs, LLC SELL $37.33 100,000 $3,733,180 57,553 -63.5%
2006-03-14 02:01 2006-03-10 LAL FAMILY PARTNERS LP 10% owner SELL $37.23 200,000 $7,446,820 2,829,302 -6.6%
2006-02-11 00:31 2006-02-09 LAUDER RONALD S Director, Officer, 10% owner - Chairman, Clinique Labs, LLC OPT+S $37.52 250,000 $9,380,550 57,553 0.0%
2006-02-10 00:26 2006-02-08 SUSMAN SALLY Officer - Exec.VP, Global Communications OPT+S $37.16 25,000 $928,915 0 0.0%
2005-11-14 22:25 2004-08-20 STERNLICHT BARRY S Director BUY $42.50 18,000 $765,000 6,000 +100.0%
2005-09-16 00:54 2005-09-14 LAUDER RONALD S Director, Officer, 10% owner - Chairman Clinique Labs, LLC SELL $39.91 80,000 $3,192,408 57,553 -58.2%
2005-09-09 23:07 2005-09-07 LAUDER RONALD S Director, Officer, 10% owner - Chairman Clinique Labs, Inc. SELL $41.10 25,000 $1,027,513 137,553 -15.4%
2005-08-25 23:10 2005-08-24 TRUST F/B/O LAUDER AERIN & JANE U/A/D 12/15/76 BY ESTEE &JHL 10% owner SELL $40.24 200,000 $8,048,400 500,000 -28.6%
2005-08-24 23:35 2005-08-22 TRUST F/B/O LAUDER AERIN & JANE U/A/D 12/15/76 BY ESTEE &JHL 10% owner SELL $41.03 550,000 $22,564,795 700,000 -44.0%
2005-08-24 22:59 2005-08-23 Bond Malcolm Officer - EVP, Global Operations OPT+S $40.76 41,666 $1,698,360 10 0.0%
2005-08-22 23:04 2005-08-19 BRESTLE DANIEL J Officer - Group President OPT+S $41.68 66,666 $2,778,926 5,367 0.0%
2005-02-19 01:38 2005-02-17 KUNES RICHARD W Officer - Exec. V.P. - CFO OPT+S $44.68 10,000 $446,750 6,468 0.0%
2005-02-15 02:11 2005-02-11 TRUST F/B/O LAUDER AERIN & JANE U/A/D 12/15/76 BY ESTEE &JHL 10% owner SELL $43.19 245,400 $10,598,090 2,000,000 -10.9%
2005-02-11 23:06 2005-02-09 TRUST F/B/O LAUDER AERIN & JANE U/A/D 12/15/76 BY ESTEE &JHL 10% owner SELL $43.45 475,000 $20,636,470 2,245,400 -17.5%
2005-02-09 23:11 2005-02-07 TRUST F/B/O LAUDER AERIN & JANE U/A/D 12/15/76 BY ESTEE &JHL 10% owner SELL $44.05 279,600 $12,315,457 2,720,400 -9.3%
2005-02-03 00:35 2005-02-01 BOUSQUET CHAVANNE PATRICK Officer - Group President OPT+S $45.10 33,000 $1,488,389 1,322 0.0%
2005-02-03 00:35 2005-01-31 CAVANAUGH ANDREW J Officer - Sr. VP- Global Human Resources OPT+S $45.56 30,000 $1,366,662 444 0.0%
2004-12-09 01:29 2004-12-07 LAUDER RONALD S Director, Officer, 10% owner - Chairman Clinique Labs, Inc. OPT+S $44.92 150,000 $6,737,505 57,553 0.0%
2004-12-07 00:25 2004-12-03 SUSMAN SALLY Officer - Sr. VP, Global Communications OPT+S $45.02 50,000 $2,251,060 0 0.0%
2004-11-20 01:17 2004-11-18 LAUDER RONALD S Director, Officer, 10% owner - Chairman Clinique Labs, Inc. SELL $44.86 146,000 $6,549,808 57,553 -71.7%
2004-11-19 00:39 2004-11-16 LAUDER RONALD S Director, Officer, 10% owner - Chairman Clinique Labs, Inc. SELL $44.92 204,000 $9,163,639 203,553 -50.1%
2004-11-16 01:30 2004-11-12 LAUDER LEONARD A Director, Officer, 10% owner - Chairman OPT+S $44.20 342,800 $15,152,788 5,369,169 0.0%
2004-11-16 01:29 2004-11-15 LAUDER RONALD S Director, Officer, 10% owner - Chairman Clinique Labs, Inc. SELL $44.73 150,000 $6,708,765 407,553 -26.9%
2004-11-12 23:25 2004-11-10 LAUDER LEONARD A Director, Officer, 10% owner - Chairman OPT+S $43.96 787,200 $34,606,886 5,411,969 0.0%
2004-09-02 17:07 2004-08-31 WENDER IRA T 10% owner SELL $43.77 3,000 $131,312 0 -100.0%
2004-08-24 00:10 2004-08-19 LAUDER RONALD S FOUNDATION 10% owner SELL $42.24 175,000 $7,391,965 36,457 -82.8%
2004-08-24 00:08 2004-08-19 STERNLICHT BARRY S Director BUY $42.26 43,000 $1,817,249 6,000 +100.0%
2004-06-11 00:33 2004-06-08 ESTEE LAUDER 2002 TRUST 10% owner, Other SELL $44.50 10,489,843 $466,798,014 0 -100.0%
2004-05-28 19:12 2004-05-27 STRAW EDWARD M Officer - President, Global Operations OPT+S $45.74 9,000 $411,621 0 0.0%
2004-05-08 00:44 2004-05-06 LANGHAMMER FRED Director, Officer - President & CEO SELL $46.73 100,000 $4,672,680 50 -100.0%
SHOW ENTRIES

How to Interpret $EL Trades

Not every insider transaction in ESTEE LAUDER COMPANIES INC is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $EL shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for EL

Insider activity data for ESTEE LAUDER COMPANIES INC is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $EL, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.